AIMC Topic: Drug Development

Clear Filters Showing 11 to 20 of 333 articles

Nebulized liposomal drug delivery: a SWOT analysis in drug development.

International journal of pharmaceutics
This critical review provided a detailed strengths, weaknesses, opportunities, and threats (SWOT) analysis of nebulized liposomal formulations, focusing on the strengths and translational potential. The formulations have notable strengths, such as en...

Revolutionizing personalized medicine using artificial intelligence: a meta-analysis of predictive diagnostics and their impacts on drug development.

Clinical and experimental medicine
Artificial intelligence (AI) is transforming the landscape of laboratory medicine by enhancing diagnostic accuracy and enabling more personalized care. Given its growing use in clinical settings, evaluating the performance of AI models in diagnostic ...

Roadmap for Commercial Nanomedicine Development: Integrating Quality by Design Principles with Pharmaceutical Nanotechnology.

Molecular pharmaceutics
Integrating Quality by Design (QbD) principles into nanomedicine development marks a paradigm shift from traditional empirical approaches to more systematic risk-based strategies. This review explores the application of QbD in pharmaceutical nanotech...

The latest advances with natural products in drug discovery and opportunities for the future: a 2025 update.

Expert opinion on drug discovery
INTRODUCTION: The landscape of drug discovery is rapidly evolving, with natural products (NPs) playing a pivotal role in the development of novel therapeutics. Despite their historical significance, challenges persist in fully harnessing their potent...

Recent advances in monoclonal antibody development for treatment of B-cell acute lymphoblastic leukemia.

Leukemia & lymphoma
Monoclonal antibody (mAb)-based therapies targeting CD19, CD20, and CD22 have revolutionized B-ALL treatment, offering precision and reduced systemic toxicity by engaging immune mechanisms to eliminate leukemic cells. This review synthesizes literatu...

Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review.

The AAPS journal
Model-informed drug development (MIDD) methods play critical role to ensure development of efficacious, and safe individualized therapies. The application of artificial intelligence/machine learning (AI/ML) within the field of drug development has ex...

Bulk Measurement of Membrane Permeability for Random Cyclic Peptides in Living Cells to Guide Drug Development.

Angewandte Chemie (International ed. in English)
Cyclic peptides are attractive for drug discovery due to their excellent binding properties and the potential to cross cell membranes. However, by far, not all cyclic peptides are cell permeable, and measuring or predicting their membrane permeabilit...

Bioactive components of Jiedu Sangen decoction against colorectal cancer: A novel and comprehensive research strategy for natural drug development.

Phytomedicine : international journal of phytotherapy and phytopharmacology
BACKGROUND: Jiedu Sangen Decoction (JSD) is widely used in the treatment of colorectal cancer (CRC) patients in southern China due to its good clinical efficacy, but the effective active ingredients are still unknown.

Advances in artificial intelligence-envisioned technologies for protein and nucleic acid research.

Drug discovery today
Artificial intelligence (AI) and machine learning (ML) have revolutionized pharmaceutical research, particularly in protein and nucleic acid studies. This review summarizes the current status of AI and ML applications in the pharmaceutical sector, fo...

Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing.

Drug discovery today
Artificial intelligence (AI) is reshaping preclinical drug research offering innovative alternatives to traditional animal testing. Advanced techniques, including machine learning (ML), deep learning (DL), AI-powered digital twins (DTs), and AI-enhan...